FI883261A - Förfarande för framställning av en farmaceutisk komposition innefattande en somatostatinanalog - Google Patents

Förfarande för framställning av en farmaceutisk komposition innefattande en somatostatinanalog Download PDF

Info

Publication number
FI883261A
FI883261A FI883261A FI883261A FI883261A FI 883261 A FI883261 A FI 883261A FI 883261 A FI883261 A FI 883261A FI 883261 A FI883261 A FI 883261A FI 883261 A FI883261 A FI 883261A
Authority
FI
Finland
Prior art keywords
preparing
pharmaceutical composition
composition containing
containing somatostatin
somatostatin
Prior art date
Application number
FI883261A
Other languages
English (en)
Finnish (fi)
Other versions
FI93308B (sv
FI93308C (sv
FI883261A0 (sv
Inventor
Thomas Cavanak
Alan Harris
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878716324A external-priority patent/GB8716324D0/en
Priority claimed from GB878716326A external-priority patent/GB8716326D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI883261A0 publication Critical patent/FI883261A0/sv
Publication of FI883261A publication Critical patent/FI883261A/sv
Publication of FI93308B publication Critical patent/FI93308B/sv
Application granted granted Critical
Publication of FI93308C publication Critical patent/FI93308C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
FI883261A 1987-07-10 1988-07-08 Förfarande för framställning av en farmaceutisk komposition innefattande en somatostatinanalog FI93308C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8716324 1987-07-10
GB8716326 1987-07-10
GB878716324A GB8716324D0 (en) 1987-07-10 1987-07-10 Organic compounds
GB878716326A GB8716326D0 (en) 1987-07-10 1987-07-10 Organic compounds

Publications (4)

Publication Number Publication Date
FI883261A0 FI883261A0 (sv) 1988-07-08
FI883261A true FI883261A (sv) 1989-01-11
FI93308B FI93308B (sv) 1994-12-15
FI93308C FI93308C (sv) 1995-03-27

Family

ID=26292476

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883261A FI93308C (sv) 1987-07-10 1988-07-08 Förfarande för framställning av en farmaceutisk komposition innefattande en somatostatinanalog

Country Status (27)

Country Link
US (2) US5753618A (sv)
JP (1) JP2578477B2 (sv)
AU (1) AU618270B2 (sv)
BE (1) BE1001079A4 (sv)
CA (1) CA1328402C (sv)
CH (1) CH677449A5 (sv)
CS (1) CS411591A3 (sv)
CY (2) CY1631A (sv)
DE (2) DE3845000C2 (sv)
DK (2) DK174125B1 (sv)
ES (1) ES2010561A6 (sv)
FI (1) FI93308C (sv)
FR (1) FR2617714B1 (sv)
GB (1) GB2208200B (sv)
GR (1) GR1000172B (sv)
HK (1) HK16492A (sv)
HU (1) HU203480B (sv)
IE (1) IE61908B1 (sv)
IL (1) IL87044A0 (sv)
LU (1) LU87268A1 (sv)
MY (2) MY109309A (sv)
NL (1) NL194823C (sv)
NO (1) NO179359C (sv)
NZ (1) NZ225340A (sv)
PT (1) PT87957B (sv)
SE (2) SE503191C2 (sv)
SG (1) SG3692G (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
PH30995A (en) * 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
US5626945A (en) * 1993-09-28 1997-05-06 International Paper Company Repulpable, water repellant paperboard
US6355613B1 (en) * 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
WO1998008528A1 (en) * 1996-08-30 1998-03-05 Biomeasure Incorporated Method of inhibiting fibrosis with a somatostatin agonist
ES2167189B1 (es) 1999-12-17 2003-04-01 Lipotec Sa Formulacion farmaceutica estable para la administracion intravenosa o intramuscular, de principios activos peptidicos
US6316414B1 (en) 2000-07-31 2001-11-13 Dabur Research Foundation Somatostatin analogs for the treatment of cancer
DK1401863T3 (da) * 2001-06-08 2009-05-25 Ipsen Pharma Kimære somatostatin-dopamin-analoge
TWI287986B (en) * 2001-12-13 2007-10-11 Novartis Ag Use of Epothilones for the treatment of the carcinoid syndrome
US20030207811A1 (en) * 2002-05-03 2003-11-06 Schrier Bruce K. Method of treating retinopathy of prematurity using somatostatin analogs
PL1787658T3 (pl) 2005-11-10 2012-08-31 Italfarmaco Spa Formulacje o przedłużonym uwalnianiu analogów somatostatyny będących inhibitorami hormonu wzrostu
EP2007370B1 (en) * 2006-03-31 2013-12-18 Erasmus University Medical Center Rotterdam Novel composition for tumor growth control
US20100160275A1 (en) * 2006-09-26 2010-06-24 Lee Eva Y H P Methods and compositions for cancer prevention and treatment
US9517240B2 (en) 2006-09-26 2016-12-13 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
US20090325863A1 (en) * 2008-06-13 2009-12-31 Kleinberg David L Somatostatin analogs and IGF-I inhibition for breast cancer prevention
GB201016433D0 (en) 2010-09-30 2010-11-17 Q Chip Ltd Apparatus and method for making solid beads
GB201016436D0 (en) 2010-09-30 2010-11-17 Q Chip Ltd Method of making solid beads
WO2012074559A2 (en) * 2010-12-02 2012-06-07 New York University Treatment of non-proliferative cystic disease
US10512669B2 (en) * 2011-06-02 2019-12-24 The Regents Of The University Of California Blockade of inflammatory proteases with cyclic peptides
CN104768565B (zh) 2012-11-01 2017-04-26 益普生制药股份有限公司 促生长素抑制素类似物及其二聚体
TWI523863B (zh) 2012-11-01 2016-03-01 艾普森藥品公司 體抑素－多巴胺嵌合體類似物

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH621770A5 (en) * 1976-02-23 1981-02-27 Sandoz Ag Process for the preparation of novel peptide compounds
IT1105131B (it) * 1977-06-08 1985-10-28 Merck & Co Inc Peptidi analoghi della somatostatina dotati di piu' lunga e maggiore attivita' biologica e relativo procedimento di protezione
LU78191A1 (de) * 1977-09-28 1979-05-25 Ciba Geigy Ag Verfahren zur herstellung von neuen cyclopeptiden
US4328214A (en) * 1979-07-04 1982-05-04 Ciba-Geigy Corporation Cyclopeptides and pharmaceutical preparations thereof and also processes for their manufacture
US4900730A (en) * 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS57188526A (en) * 1981-05-14 1982-11-19 Takeda Chem Ind Ltd Peptide-containing pharmaceutical preparation
US4374060A (en) * 1981-07-15 1983-02-15 Merck & Co., Inc. Process for the preparation of cyclic hexapeptide
DE3264693D1 (en) * 1981-12-24 1985-08-14 Ciba Geigy Ag Cyclic octapeptides and pharmaceutical compositions thereof, and processes for their production and use
US4522813A (en) * 1983-10-27 1985-06-11 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
CH666035A5 (de) * 1984-12-24 1988-06-30 Sandoz Ag 8-alpha-acylaminoergolene.
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体
GR862206B (en) * 1985-09-12 1986-12-31 Univ Tulane Therapeutic somatostatin analogs
NL8701143A (nl) * 1986-05-27 1987-12-16 Sandoz Ag Farmaceutische preparaten.
HU906340D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Synthesis in solid phase for producing peptonic alcohols
AU639371B2 (en) * 1987-07-10 1993-07-22 Novartis Ag Method of treating breast cancer
US5187150A (en) * 1987-10-14 1993-02-16 Debiopharm S.A. Polyester-based composition for the controlled release of polypeptide medicinal substances
AU2284588A (en) * 1988-09-26 1990-03-29 Sandoz Ltd. Improvements in or relating to organic compounds
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
US5384309A (en) * 1989-07-17 1995-01-24 Genentech, Inc. Cyclized peptides and their use as platelet aggregation inhibitors
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体

Also Published As

Publication number Publication date
DK200100558A (da) 2001-04-04
GB8816024D0 (en) 1988-08-10
NO179359B (no) 1996-06-17
CY1631A (en) 1992-07-10
ES2010561A6 (es) 1989-11-16
JPS6431728A (en) 1989-02-02
FI93308B (sv) 1994-12-15
IE61908B1 (en) 1994-11-30
DE3845000C2 (de) 1998-11-19
SE8802569D0 (sv) 1988-07-08
DK174125B1 (da) 2002-07-01
DE3822557A1 (de) 1989-01-19
PT87957A (pt) 1989-06-30
MY103746A (en) 1993-09-30
NO883054D0 (no) 1988-07-08
NL194823B (nl) 2002-12-02
PT87957B (pt) 1995-03-01
CH677449A5 (sv) 1991-05-31
SE9301290D0 (sv) 1993-04-20
US6066616A (en) 2000-05-23
DK174476B1 (da) 2003-04-14
MY109309A (en) 1997-01-31
BE1001079A4 (fr) 1989-07-04
GR880100458A (en) 1989-04-12
AU618270B2 (en) 1991-12-19
JP2578477B2 (ja) 1997-02-05
JPH0748272A (ja) 1995-02-21
GB2208200B (en) 1991-11-27
FI93308C (sv) 1995-03-27
CA1328402C (en) 1994-04-12
SE8802569L (sv) 1989-01-11
NO883054L (no) 1989-01-11
HK16492A (en) 1992-03-06
JP2764041B2 (ja) 1998-06-11
NL8801734A (nl) 1989-02-01
AU1889388A (en) 1989-01-12
GB2208200A (en) 1989-03-15
SE9301290A0 (sv) 1993-04-20
SE503191C2 (sv) 1996-04-15
FI883261A0 (sv) 1988-07-08
FR2617714B1 (fr) 1991-09-20
NO179359C (no) 1996-09-25
DK385488A (da) 1989-01-11
DK385488D0 (da) 1988-07-08
LU87268A1 (fr) 1989-03-08
SG3692G (en) 1992-03-20
IL87044A0 (en) 1988-12-30
CS411591A3 (en) 1992-06-17
IE882091L (en) 1989-01-10
HUT47865A (en) 1989-04-28
NZ225340A (en) 1991-05-28
NL194823C (nl) 2003-04-03
CY1632A (en) 1992-07-10
US5753618A (en) 1998-05-19
FR2617714A1 (fr) 1989-01-13
DE3822557C2 (de) 1998-07-02
GR1000172B (el) 1991-11-15
HU203480B (en) 1991-08-28

Similar Documents

Publication Publication Date Title
FI881978A (sv) Förfarande för framställning av en farmaceutisk sammansättning, som innehåller eperison
FI883261A (sv) Förfarande för framställning av en farmaceutisk komposition innefattande en somatostatinanalog
FI892640A (sv) Förfarande för framställning av en piperidinoalkanol-ibuprofenkomposition innehållande farmaceutisk komposition
HUT42321A (en) Process for preparing pharmaceutical compositions
PT86866A (pt) Process for preparing piperazinyl-heterocyclic compounds
FI894342A0 (sv) Förfarande för framställning av en cyklosporin innehållande farmaceutisk sammansättning
HUT43954A (en) Process for preparing peroral pharmaceutical
FI98192B (sv) Förfarande för framställning av en näringskomposition
IL85741A0 (en) Substituted 9-amino-tetrahydroacridines and related compounds,a process for their preparation and pharmaceutical compositions containing them
PT86437A (en) Process for preparing a pharmaceutical composition containing piroxicam
HUT49481A (en) Improved process for producing pharmaceutical compositions containing calcium-salts
HUT47428A (en) Process for producing retarde pharmaceutical compositions containing ketotifen
FI98731B (sv) Förfarande för framställning av superaktiva insulinanaloger
PT84213A (en) Process for preparing a long acting sustained release pharmaceutical composition
GR862030B (en) Method for preparing pharmaceutical compositions
PT88682A (pt) A process for the preparation of pharmaceutical compositions containing a piperidinoalkanol-decongestant combination
PT87672A (pt) Process for preparing a pharmaceutical composition
FI98127C (sv) Förfarande för framställning av en stabiliserad farmaceutisk komposition
PT88681A (pt) A process for the preparation of pharmaceutical compositions containing piperidinoalkanol derivatives
HUT46534A (en) Process for producing pharmaceutical composition containing benzopirane-2-carboxylik acid derivative
EP0236929A3 (en) 1,2-dithiol-3-thione derivatives, a process for preparing them and a pharmaceutical composition containing them
PT87564A (pt) Process for preparing substituted vinylcephalosporins useful as medicaments
GR890100177A (en) Process for preparing pharmaceutical compositions containing sodium cromoclycate
EG18306A (en) A process for the preparation of pharmaceutical compounds
FI873548A (sv) Förfarande för framställning av en oktreotid innehållande farmaceutisk sammansättning

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

FG Patent granted

Owner name: NOVARTIS AG